Adidas has been one of the leading manufacturers of sports gear including shoes for many years now. The brand Adidas is associated with great quality and durability besides making a style statement in the world. Adidas shoes have been for so long a benchmark of the manufacturing standards in the shoe industry. Today, we will present you with the best Adidas sports shoes available currently in the market.
Your perfect companion for an early morning jog, the Boost ESM is the perfect road running shoe designed to offer you mild support on your mid-foot area while running. Available in 8 different color options, the Boost ESM has earned good reviews from a number of professional athletes for the presence of the mid-sole technology which puts less pressure on your feet and provides extra support to them.
Another great quality road running shoe from Adidas is the Supernova Glide Boost. This shoe is perfect for people who like to go on long distance runs throughout the day and the padded interior and a comfortable sole makes sure that your feet are well supported and protected. The shoe comes in 8 different color options and the boost technology used on the shoe helps to attenuate the impact on your feet while jumping or landing.
The very popular boost range of Adidas shoes provides you with another option for your daily running activities. The Response Boost 2 uses the Boost mid-sole technology to lighten the pressure on your feet while distance running and provides you with an energy boost to the toes. The shoe is one of the best durable running shoe you will ever come across in the market. The shoe feels very lightweight while running because of the foam padding around it.
The Terrex Swift R from the Adidas shoe range is highly suitable for those runners who go on for running around the terrain regions. The shoe includes waterproofing features to protect it from getting too wet in case of rains or collected water on roads. It has a brilliant grip on the mountain road or on the off-road terrain for which the shoe is purposely built for. However, one drawback to the added grip and cushioning on the shoe is the additional weight of the shoe in comparison to other models.
The Alpha Bounce road shoe from Adidas is the latest shoe in line to make a mark on the market across the globe. The shoe features a state of the art mesh technology on the upper portion to provide added comfort and flexibility to the shoe. The new Bounce mid-sole technology used on the shoe helps to provide support to your foot. The overall design of the Alpha Bounce allows the people to use the shoe in many different activities.
Adidas Shoes have been the standard bearer in the market for a long time and with the launch of a number of great products as mentioned above, it will surely be at the top of the charts for many more years to come.…
Young generation’s love for Fastrack wrist watches is no hidden truth. These watches have got some funky style and trending design that captures the mind of young people. College students love to wear these funky watches from Fastrack as it enhances their personality and increases their style quotient. Let’s see some of the trending funky Fastrack watches young people love to wear.
Designed in a black shade, Fastrack casual digital black dial watch is a lighter watch that weighs only 168 grams. It features a digital analogue with black background that displays the time whereas the silicon black band gives an edgy touch to the watch. It’s a water resistant watch for up to 50 meters depth. The company has set its price at INR Rs 1,999.
Fastrack analog green dial watch has got decent design and subtle style. The dial comes with multi color shade whereas the numerals style is unique. The watch that weighs around 200 grams has quartz movement mechanism and is water resistant up to 50 meters. The silicon strap of the watch is given a black color which suits it. The watch is priced at INR 1,924.
Fastrack upgraded silver dial watch is a wonderful watch designed to go well with any attire you wish to wear. The strap is built using stainless steel and comes in silver color. It also features deployant clasps and analogue display with a silver dial color. It is one of the lightest weighing Fastrack watch in the market. It comes with a price tag of INR 1,700.
A popular choice among youngsters, fastrack OTS analog watch is equipped with Quartz mechanism. The design and style of the watch is impressive which is capable of attracting young people. It has a synthetic band and analogue display which is made using acrylic. Buckle clasps provides strong grips that prevents the watch falling off the wrist. You can find New OTS analogue watch in stores or at online portals with a price tag of INR 1,329.
Fastrack Economy Analog Blue Dial Watch is undoubtedly one of the most attractive funky Fastrack watches you will find in the stores. It has blue dial with attractive design in the background and the brand logo at the right side. The only drawback of the watch is that it weighs 200 grams, slightly heavier than other Fastrack watches. You can buy this impressive watch at INR 1,900.
If you wish to buy a cost effective funky fastrack watch, then Fastrack casual analog black dial watch is the perfect fit for you. The black dial features green color numerals that give the watch its funky look. It’s a water resistant watch for up to 30 meters depth. The watch comes with an affordable pricing of INR 750.
Each fastrack watch mentioned above has got great looks and some unique features. Moreover, the pricing is what sets Fastrack apart from the rest of the brands. Choose any of them and you will be delighted by its funky looks, this is what all the Fastrack watches promise.…
Dubai based Mumbai Actress Andria D’Souza bags Emerging Actress Award
International recognition at Asia’s Biggest Leadership Conclave recognizes Andria D’Souza’s upcoming sizzling performance for Faisal Saif’s Controversial Picture For Adults Only
Andria D’Souza, the glamorous actress from Dubai currently based in Mumbai is in the news lately for her much awaited next upcoming “boldest” and “dirtiest” multilingual film For Adults Only”considered to be the most controversial picture in recent times of the versatile Director Faisal Saif’s game-changer in Indian cinema. The pretty actress Andria D’Souza also fondly called as Ria has signed the mind-boggling script in association with Dimension Pictures where the Hollywood’s busty actress kim kardashian is said to be roped in for the first time in Indian cinema. For Adults Only is being made in Hindi, Telugu and Tamil languages and the film is scheduled to be released next year, currently under research stage. The gorgeous & curvy actress Andria D’Souza will be playing the lead role & is expected to show intimate scenes with the lead actor where the Actress is being portrayed in different shades & the character is being shown in a unique way with many twists & turns. Andria says that she has a strong Indian connection & though born in Dubai, my heart has always been in Mumbai. Prior to this, Andria made her mark as a video jockey in Dubai & a successful model before culminating into the epic movie Kamasutra 3D. Andria D’Souza played an Arabian queen in the erotic flick based on Vatsyayana’s Kama Sutra, an ancient Indian text and one of the most widely read works on human sexuality. Asked if she had inhibitions while doing sexually explicit scenes, Ria, originally from Mangalore, India, said: “I was cast opposite Milind Gunaji and had just one intimate scene. I must say I was freaking nervous, but director Rupesh Paul put me at ease and shot it very aesthetically. At the end of the day, we are actors and have to do what the script demands.”
Bollywood has been considered as world’s second biggest film industry in the world in which numerous films have been produced each year after Hollywood.The Indian film industry has largely been dominated by top actors & actress. There are numerous Bollywood actresses who managed to catch public eyes following their stunning and gorgeous looks, versatile skills and talent. Now comes to hottest actresses of Indian cinema which sizzled on the floor and able to heat up the audience from their hot and sexy performance on stage. Dubai based Andria D’Souza is set to make her mark in creative Director Faisal Saif’s boldest & dirtiest movie For Adults Only.
Announcing the name of the very talented & creative Andria D’Souza, the jury members of Network 7 Media Group said” The selection of Andria D’Souza as the Emerging Actress of the year was driven primarily because of the forward looking approach of the beautiful actress Andria & the ability to defy the conventional norms of doing the sterotype roles where the story is based on an predicted line. Andria D’Souza while in news for signing a couple of meaningful movies, is also, said to be heading for a Hollywood to be signed by a big banner production. Born and raised in Dubai, Ria studied at Our Own English High School. She worked as a radio jockey with a local FM channel and then as a TV host for ZEE TV Middle East before making her movie debut in 2012 with Malayalam romantic thriller Casanovva staring south Indian film star Mohanlal. Kamasutra 3D was shown at the 66th Cannes International Film Festival and was also in the contention list of the 86th Academy Awards.
Andria D’Souza will be receiving the recognition in a star studded glittering award night of ILC 2015. The Award Presentation will be held at Mumbai, India on Friday, the 21st September 2015 at Hotel Sahara Star in a glittering award ceremony from 07.30 PM onwards where India’s who’s & Who’s will be present like previous years to celebrate the moment of joy, happiness & success. We need your physical presence with your team members to receive the award in person. We will periodically keep you informed on the latest updates. More than 300 industry leaders, diplomats, policy makers, social activists, business tycoons, rebel leaders are expected to attend the much awaited annual affair including delegates from the middle east, Europe & asean countries. The grand conclave ILC 2015 will also felicitate leaders & Companies for the remarkable performances for making india move, proud & prosper. India Leadership Conclave platforms over the last six years of successful uninterrupted editions has felicitated many top iconic Iconic leaders like Ratan Tata, Mukesh Ambani, late former prime minister Rajiv Gandhi, Arvind Kejriwal, Priyanka Chopra, Kiran Mazumdar shaw, Narayan Murthy, Anna Hazare, Kiran Bedi, Arvind Kejjriwal, Nandan Nilekani, are few of the names who are the recipients of the awards in various categories.
Rated by Experts & widely acclaimed by thought leaders, India Leadership Conclave Annual Affair is just not a leadership forum, it symbolizes the hopes & aspirations of the billion people reflected by the speakers at the forum. “ILC POWER BRANDS” has been rated in Asia as the most credible & coveted Awards developed by Network 7 Media Group consisting of eminent jury members of the different verticals of the society & is conferred to the Individuals & Companies in its annual meet at the Indian affairs India Leadership Conclave & Indian Affairs Business Leadership Awards. since the institutionalization of the Business Leadership Awards in 2010, India Leadership Conclave & Indian Affairs Business Leadership Awards has been India’s most awaited & asia’s most respected set of Awards conferred to Companies & Individuals who have made their mark through their remarkable performances despite all odds & has made India Proud!. Since the last five successful years, the platform has recognized, felicitated more than 300 fortune 500 Companies & towering captains & Leaders of the Country
Bollywood has been considered as world’s second biggest film industry in the world in which numerous films have been produced each year after Hollywood.The Indian film industry has largely been dominated by top actors & actress. There are numerous Bollywood actresses who managed to catch public eyes following their stunning and gorgeous looks, versatile skills and talent. Now comes to hottest actresses of Indian cinema which sizzled on the floor and able to heat up the audience from their hot and sexy performance on stage. Dubai based Andria D’Souza is set to make her mark in creative Director Faisal Saif’s boldest & dirtiest movie For Adults Only.…
Controversial Director Faisal Saif to receive the prestigious “Critics Choice Movie Award for Best Director” at 6th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2015
Filmmaker Faisal Saif known for making controversial films in Bollywood as well as regional south Indian destinations has been voted by the Network 7 Media Group’s eminent jury for the coveted & prestigious “Critics Choice Movie Award for Best Director” at its 6th annual affair to be hosted in Mumbai on Friday, 21st August 2015, Indi. Network 7 Media Group ( www.network7mediagroup.net ), Asia’s Most Definitive & Credible News Media in Mainstream Journalism is hosting its high profile leadership event under its banner Indian Affairs ( www.indianaffairs.tv ) on a aptly theme “India @ 58” : Learning Lessons From The Past And Restrategizing For The Future” at the 6th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2015 where india’s biggest thought leaders will be present to listen the topics of tremendous significance confronted by the complex issues that the Nation is facing. Besides India, the event will witness participations from the countries such as Europe, Middle East & south east countries. The prestigious Leadership Awards will be conferred to the deserving individuals & companies in both voting as well as non-voting categories.
Announcing the name of Faisal Saif for the final selection as Critics Choice Movie Award for Best Director”, Satya Brahma, Chairman & Editor-In-Chief of Indian Affairs said “ The Award & Recognition to Faisal Saif signifies the remarkable accomplishments of the young Filmmaker for bringing off-beat stories, breaking conventional films norms & applying the innovations in directing. Faisal Saif is a committed & proved professional in Film Making. The reasons for selkecting Faisal Saif out of many deserving Directors are his abilities to work under a constrained budget without compromising the quality inputs”. In a congratulatory email to Faisal Saif, Satya Brahma stated that “You rose to fame with the movies like Jigyaasa, Main Hoon Rajinikanth and Amma. You believed in making films that are mostly on the lines of reality cinema. Your movie Jigyaasa undoubtedly brought you into limelight as a controversial film maker. You started your career as an independent music video director and directed videos for Catrack Music and Vital Records. You made your first movie in 2003 which received International award from Indianapolis LGBT Film Festival in best story telling. You are also the Co-Editor in Global Movie Magazine and also a Film Critic. Your upcoming Movie titled For Adults Only which is a trilingual Movie to be made in Hindi, Tamil and Telugu to be produced by Dimension Films. As a director of a substance, you are one of the most popular, controversial and acclaimed film director of making offbeat stories & making the headlines. You are also a rare director who makes films that are both action-packed, special effects-laden blockbusters and high quality, critically acclaimed works of art. Indeed you credit your enormous success to your tireless work ethic, obsessively working and reworking a film until the last possible moment. Theres no such thing as perfection, as you say. Youre never finished with a film. You run out of time. Satya added
India Leadership Conclave platforms over the last six years of successful uninterrupted editions has felicitated many top iconic Bollywood stars such as Late Yash Chopra, Rani Mukerjee, Priyanka Chopra, Anushka Sharma, Fashion Designers Manish Malhotra, Babita Malkani & Shraddha Kapoor.
The Controversial Director will be receiving the top recoignition at a star-studded glittering award night on 21st August in a suburban Hotel in Mumbai, Maharashtra, India where India Leadership Conclave will felicitate more than 30 top Leaders of the Country.
India’s Dr. Datsons Labs Ink Marketing And Supply Agreement with Yemen’s AL-MUGDH PHARMA to sell its drugs in YEMEN. Dr. Datsons Labs to export Anti-Malarial Drugs worth 80 Crore to Yemen, deal to boost Dr. Datson’s export business.
Dr. Datsons Labs Ltd, India and AL-MUGDH PHARMA of Yemen have signed a licensing, distribution and supply deal, under which the distribution company will market Anti-Malarial Drugs. Dr. Datsons Labs Ltd, HSL Code: AANLIF, BSE Code: 533412, NSE Symbol: DRDATSONS,ISIN INE928K01013 should trade higher after entering into a binding Memorandum of Understanding with Almugdh Pharma, Yemen to distribute its anti-malarial product. Shares of Dr.Datsons Labs Limited was last trading in BSE at Rs.6.70 as compared to the previous close of Rs. 6.97. Once the darling of the stock market, Dr. Datsons Labs has been on a series of downfalls following the market conditions. Experts believe that with the new Management at the helm effected by the Board this month, some aggressive actions may be noticed including the deals underway with overseas companies for capital inflow. The Company is also looking to widen its product basket to cater to the regulated & semi regulated market.
According to Mr. Sameer Talim, CEO, Dr. Datsons Labs Ltd, “the talk between the two companies was going on for the last six months & there are certain regulatory aspects that need to be addressed before the commercialization of the 5 products to be exported to AL-MUGDH PHARMA. These products include Codeine Phosphate U.S.P. 30 mg , ARTESUNATE 100 MG + AMODIAQUINE 270 MG, MEFLOQUINE HCL 250MG+ARTESUNATE 200MG, ARTESUNATE 50 MG + AMODIAQUINE 153 MG,QUININE SULPHATE 300 MG. “. Dr. Datsons Labs is revamping its factory in Pune to cater to the overseas market. The estimated order for the Yemen is to the tune of 80 crore. We also have a commitment to manufacture Nutraceuticals for Belgium company Eubage which is awaiting for the final clearances.
It may be note that The pharmaceutical market in Gulf Cooperation Council (GCC) countries and specially Yemen is growing rapidly and is projected to grow into an estimated US$10-billion industry by 2020. There were 46 pharmaceutical manufacturing plants in the GCC and Yemen in 2010. The combined investments of the region in this sector during the same year stood at US$830-million, providing jobs for 8,000 people, yet the region still imports the bulk of its medicines. This industry was growing six percent annually but local pharmaceutical companies have not been able to meet this growth. The GCC and Yemen was currently importing 90% of its medicines. “There are significant opportunities for growth and expansion of this sector in the GCC so that in future it will be able to meet a substantial part of the requirements of the region with the possibility of exporting them to neighboring countries,”
AL-MUGDH PHARMA is Yemen’s leading healthcare firm engaged in import, distribution and marketing agents of pharmaceuticals , medical disposables and medical appliances. Ministry Of Health, Chamber Of Commerce and Ministry of Industry and Trade has recognized AL-MUGDH PHARMA as one of the leading Pharmaceutical importer , wholesaler and distributors for branded & amp; generic products of major multinationals , & amp; Multinational companies and surgical products , Eye drops & it has a good base of clients, a net of distributors equipped with all facilities and well educated and trained ones.
Dr.Datsons Labs Ltd., formerly Aanjaneya Lifecare Limited, is an India-based integrated pharmaceutical company. The Company is engaged in the manufacturing and marketing capabilities in Contract Research and Manufacturing Services, and active pharmaceutical ingredients. The Company focuses on anti-malarial and finished dosage forms (FDFs), catering to diverse therapeutic segments. The Company manufactures second generation anti-malarial APIs like quinine and salts as well as third generation anti-malarial products like Artemisinin-based salts. The Company engages in contract manufacturing for leading Indian pharmaceutical brands namely Wockhardt, Cipla, Zydus Cadila, Lupin and Glenmark, among others. The Company’s subsidiaries include Eros Pharmachem Pte Limited, Aanj Pharmalabs Limited Fze, Fair Success (Hongkong) Limited and Dr. Datsons Labs Limited (the United Kingdom.…
Indian Pharma Industry Needs a Big Investment Reforms & Push from Transformational Union Budget 2015-16 Dr. Rajendra Kamat , VC & MD, Dr. Datsons Labs Ltd. Mr. Mahesh Vaidya, Vice-chairman & MD of Dr. Datsons Labs expressed hope that the Finance Minister Arun Jaitley will accord enhanced tax incentives for research and development (R&D) activities in the pharmaceutical sector in the forthcoming Budget to be announced on February 28. In its Budget proposals, the Commerce Ministry has sought weighted average tax benefit of 400 per cent for R&D activities for the sector.
Midsized companies like us will look at more positive agenda & push from the forthcoming budget & clarity of direction on tax reforms & FDI.
There is an urgent need to boost R&D in the pharma sector. India is the hub of generic medicines. It contributes significantly to the countrys total exports, Mr Vaidya expressed that the industry will get fresh incentives as annually, India exports pharmaceutical products worth $10 billion. The market size of the industry is around Rs. 1 lakh crore.The need for special financial package for the pharma sector has been highlighted in various fora.The pharma sector is a capital intensive sector. Besides R&D expenditure, regulatory requirements require large funds. All quality investments should be treated on par with R&D to provide incentives to the industry, the official added.
Dr. Datsons Lab Ltd, formerly known as Aanjaneya Lifecare Ltd, BSE code (533412) is a vertically integrated company having state-of-the-art; WHO GMP approved facilities for manufacturing bulk drugs at Mahad and finished dosage forms at Pirungut near Pune. It is one of the largest contract manufacturers of codeine based cough syrups in India. The company exclusively manufactures the Codorex Brand of Zydus Cadilla and Codilite Brand of Tablets India Ltd. amongst others.The company raised about Rs. 117 crore from its IPO and the funds are being used to built new capacities along with the refurbishing of Research & Development centre. The new facilities being created as part of CAPEX are using eco friendly, recyclable material and will be rated by LEEDS once completed.The Facilities being established will comply with the latest European & US guidelines. With new capacities to be added in next 6 to 9 months the company will be expanding operations in emerging markets of South East Asia, Africa & South & Central America and its domestic operation in branded generics segment. The company with its manufacturing facilities –in Mahad, Hyderabad and Pune has to its credit many achievements. It is the world’s third-largest manufacturer of quinine salts in the world . Only nine companies globally manufacture quinine salts.One of the largest codeine based formlulations manufacturer in the pharmaceutical sector. One of the largest manufacturer of multi- flavored Lozenges in medical products in India. The company pioneered the recognition that lozenges represent a stable platform for the delivery of pharmaceutical and nutraceutical ingredients. Dr. Datson’s Nicco Nil lozenge is a first-of-its-kind hard boiled lozenge remedy for smoking de-addition; its Relacs is a first-time lozenge against insomnia and Arecta Plus, a lozenge variant for Erectile Dysfunction, is a first of its kind . The company has an expertise in opportunity spotting and innovation. The company’s success has been built on a business model that integrates Research, Innovation and Knowledge. The company has invested in building proprietary Knowledge through research and acquisitions. Dr. Datson’s competence has been validated through patents granted by international and Indian authorities. Production of Quinine Sulphate increased 30% in 2011-2012. Sales of Quinine Sulphate grew 45%. Exports increased 250% from Rs 10 Crore to Rs 31 crore. Added 35 international and 50 domestic clients. Completed trials for Bromexine(expectorant)a new API that will be launched in 2012-1023. Highlights 2011-2012 for Finished Dosage Forms. Launched ‘Rancorex’ an in-house codine based cough syrup brand for the first time in its history. received the Kenya PPB GMP approval from all facilities namely lozenges,liquids and ointments. Received registration for ‘Arecta Plus’(a lozenge variant of Viagra tablets)from Sierrs Leone and Libya; received the first export order for this product to be executed in 2012-2013.…
Saturday, 14th February 2015, Mumbai, Maharashtra. In a major development to the top leadership change in the listed Pharma Company Dr. Datsons Labs Ltd, the announcement has come from the Meeting of the Board of Directors of the Company held on February 14, 2015. The salient features of the unaudited financial results seem to indicate a positive vibe as the sales is up 15% & net profit up from 1.97lakhs to 1.99 lakhs
Dr.Datsons Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2015, inter alia, has decided to appoint Mr. Mahesh Vaidya, as the Vice Chairman and Managing Director of the Company w.e.f. February 14, 2015. Dr. Kannan Vishwanath, as the Vice Chairman and Managing Director of the Company has stepped down from the post w.e.f. February 14, 2015. Dr.Datsons Labs Ltd had earlier appointed Mr. Sameer Talim as the Chief Executive officer of the Company, with effect from February 09, 2015.
Sources to Pharmaleaders reveal that the appointment of Mr. Samir Talim as the CEO of Dr. Datsons Labs Ltd will be primarily to drive the company’s presence in the major markets & to aggressively build on the export orders, work on existing clients & as well as to generate new business give push to the Generic barands of Dr Datsons in Middle East, South East asia & South America. The new CEO will also push Registrations of our formulations & enter new markets using his expertise in these markets. Mr. Samir has wide exposures in the export markets based on his successful stints in the previous assignments will help Dr. Datsons Labs penetration into the key market. India ofcourse will remain as the Key market as the company still has big companies in Contract Manufacturing. Mr. Mahesh Vaidya as the new Vice-Chairman & Managing Director will aggressively look into equity raising for the company. Mr. Mahesh Vaidya is entrusted with the responsibilities to meet with the potential investors for stake sale or fresh infusions of funds into the company which is quite vital for the growth momentum of Dr. Datsons Labs. Ltd. There are key unfinished agenda as certain vital deals are yet to be given a finishing end including the current proposals to give new & fresh perspectives.
In an exclusive interview to Pharmaleaders ( www.pharmaleader.tv ), the new Vice-Chairman & MD, Mr Mahesh Vaidya expressed hope that the coming I year is going to be very crucial to the company’s both organic & inorganic growth as many deals, JV’s & partnership are pending for the final clearances, Dr. Datsons Labs will be closely looking at the operational efficiency of the Mahad Facility for Making APIs for Captive Use of APIs for their formulations. There are interesting & exciting times ahead of us, we all are committed to bring the company to its new height. Commenting on the state of india’s booming Pharma market, Mr Vaidya stated that India has become a prime destination for manufacture of branded, generic and branded generic medicines with a strong export element. It is estimated that around 40 per cent of the generic drugs in the US come from India and with Obamacare being introduced this figure is set to rise further. Overall market seems positive & our new CEO Mr. Sameer Talim will drive the domestic as well as the exports market, soon we will announce a breakthrough export deal that we have received from Nigeria & Yemen.
Mr. Sameer Talim stated that “Indian pharmaceutical companies have capitalised on export opportunities in regulated and semi-regulated markets and pharma exports from India grew at a CAGR in excess of 20% from 2006 to 2012. Currently, India is the third-largest exporter of Active Pharmaceutical Ingredients (APIs). Indian pharma exports are expected to bring in an estimated $40 billion by the First Quarter of 2015. With Indian products competing with their global counterparts in terms of quality, India has been able to establish a global footprint. Indian companies operating in the west have been able to do so successfully & Dr. Datsons Lab is fully equipped to meet the challenges both regulatory & operationally to cater to the world market. We are expecting a 30 % jump in exports in the second quarter which will largely be driven by the generic push”.
Mr Sameer Talim, CEO, Dr. Datsons Labs Ltd.
Mr Sameer Talim is an B.COM & MBA from Mumbai University with entire Experience Based in West Africa in Healthacare Marketing. He started as Management Trainee with Kinds Healthcare Limited Kampala & Rose to Become The Vice President Marketing & Operations at Sparkeway Industries in Kampala. In last 20 years he has extensive experience in West African Markets for marketing registration & Distribution of Anti Malarial Drugs, HIV & AIDS Medication. He has returned to India after 20 years due to person & domestic requirements. He has joined us & will spearhead our growth operations for Exports worldwide. Mr Sameer repeatedly produce sustained revenue and EBITA growth in dynamic and changing markets. Has proven achievements and Extensive business background in international, multi-cultural environments. Mr. Sameer is a results-oriented Healthcare CEO with over 25 years’ experience as a Senior Executive. Strong reputation in executive leadership, strategic planning, business development, fiscal and organizational management. Demonstrated results in quality management, revenue cycle improvement and financial turnarounds. Worked in both for-profit and not-for-profit healthcare organizations and systems. Superb decision making and problem solving skills. High-energy people-person with strong communication and interpersonal skills & a Senior executive with verifiable year-after-year success achieving revenue, profit, and business growth objectives within start-up, turnaround, and rapid-change environments. Extensive experience with highly engineered systems, which require deep understanding of critical business drivers in multiple markets and industries; highly successful in building relationships with upper-level decision makers, seizing control of critical problem areas, and delivering on customer commitments.
Mr Mahesh Vaidya
Vice Chairman & MD, Dr. Datsons Labs Ltd.
Mahesh Vaidya is a top Management Professional with over 25 years of experience in the field of Finance,Accounts, Overall Business Development. This dynamic young MD of Dr Datsons Labs, started his career with couple of Pharma Companies through his hardwork and dedication earned the highest position in the organisation. His leadership witnessed dramatic growth and through his aggressive positioning and strategy the organisation won many laurels and awards in past. As the new VC & MD of the company, Mahesh will spearhead Dr Datsons Labs’s’s aggressive game plan to accelerate growth and take advantage of the changing business dynamics that emphasize equally, aspects of product portfolio, quality, global footprint and cost efficiency. Mahesh has a meritorious track record, and the experience of managing large business operations earlier, with similar responsibilities.
Mr Mahesh Vaidya is BSC & MSc It from Pune University. He has over 25 years experience working in global markets . He started His career with Pharmed Europe Ltd looking into their Medical devices Business. He rose to Position of Head of commercial operations in one year looking into their entire exports of Medical devices worldwide. From Pharmed Limited Europe he Moved to Quibarkfarm Global S.A. As Director Exports to looking into entering generic markets in South America Till January 2015. He has been appointed as the Vice Chairman & Managing Director. Repeatedly produce sustained revenue and EBITA growth in dynamic and changing markets. Proven achievements and Extensive business background in international, multi-cultural environments. Senior executive with verifiable year-after-year success achieving revenue, profit, and business growth objectives within start-up, turnaround, and rapid-change environments. Extensive experience with highly engineered systems, which require deep understanding of critical business drivers in multiple markets and industries; highly successful in building relationships with upper-level decision makers, seizing control of critical problem areas, and delivering on customer commitments. Mr Vaidya has shown remarkable achievements in Excellent marketing skills, exceptional ability to communicate orally and in writing, has experience of sales metric designs & demonstrated ability to work in a leadership role. A far sighted individual withover 25 years’ experience in excellent business development skills with hands on knowledge of directing the activities of all projects. Excellent knowledge of supporting the company’s strategic alliances and participating in marketing strategies. Hands on experience of supervising employees across different departments in order to facilitate the process of production and marketing. Mr. Vaidya has hands on experience on operations management, Acquisitions & Integrations, Organic Business Growth,Strategic Planning Staff Development-Promotion, Performance & Quality Standards,Customer Satisfaction & Allegiance Leadership Development, P&L Management/Budget Planning, Engineering & Manufacturing Change Management, Commercial & Customer Support Strategic Partnerships. As Vice Chairman & Managing Director of Dr. Datsons Labs Ltd, Mr Mahesh Vaiday will be the driving spirit of leadership to the Board & will undertake strategic initiatives to propel the growth engine of the Company. Mr Mahesh Vaiday will have the responsibilities to identify and direct business development activities, ensure that all corporate objectives are pursued & organize activities for business development, develop strategic business plans, establish company culture, values and vision manage risk management plans.
About Dr. Datsons Lab Ltd
Dr. Datsons Lab Ltd, formerly known as Aanjaneya Lifecare Ltd, BSE code (533412) is a public listed vertically integrated company having state-of-the-art; WHO GMP approved facilities for manufacturing bulk drugs at Mahad and finished dosage forms at Pirungut near Pune. It is one of the largest contract manufacturers of codeine based cough syrups in India. The company exclusively manufactures the Codorex Brand of Zydus Cadilla and Codilite Brand of Tablets India Ltd. amongst others.The company raised about Rs. 117 crore from its IPO and the funds are being used to built new capacities along with the refurbishing of Research & Development centre. The new facilities being created as part of CAPEX are using eco friendly, recyclable material and will be rated by LEEDS once completed.The Facilities being established will comply with the latest European & US guidelines. With new capacities to be added in next 6 to 9 months the company will be expanding operations in emerging markets of South East Asia, Africa & South & Central America and its domestic operation in branded generics segment. The company with its manufacturing facilities –in Mahad, Hyderabad and Pune has to its credit many achievements. It is the world’s third-largest manufacturer of quinine salts in the world . Only nine companies globally manufacture quinine salts.One of the largest codeine based formlulations manufacturer in the pharmaceutical sector. One of the largest manufacturer of multi- flavored Lozenges in medical products in India. The company pioneered the recognition that lozenges represent a stable platform for the delivery of pharmaceutical and nutraceutical ingredients. Dr. Datson’s Nicco Nil lozenge is a first-of-its-kind hard boiled lozenge remedy for smoking de-addition; its Relacs is a first-time lozenge against insomnia and Arecta Plus, a lozenge variant for Erectile Dysfunction, is a first of its kind . The company has an expertise in opportunity spotting and innovation. The company’s success has been built on a business model that integrates Research, Innovation and Knowledge. The company has invested in building proprietary Knowledge through research and acquisitions. Dr. Datson’s competence has been validated through patents granted by international and Indian authorities. Production of Quinine Sulphate increased 30% in 2011-2012. Sales of Quinine Sulphate grew 45%. Exports increased 250% from Rs 10 Crore to Rs 31 crore. Added 35 international and 50 domestic clients. Completed trials for Bromexine(expectorant)a new API that will be launched in 2012-1023. Highlights 2011-2012 for Finished Dosage Forms. Launched ‘Rancorex’ an in-house codine based cough syrup brand for the first time in its history. received the Kenya PPB GMP approval from all facilities namely lozenges,liquids and ointments. Received registration for ‘Arecta Plus’(a lozenge variant of Viagra tablets)from Sierrs Leone and Libya; received the first export order for this product to be executed in 2012-2013.…